A Multifunctional Polyester Nanoplatform for the Synergistic Anticancer: Enhanced Photodynamic Therapy and Targeted Gene Silencing

X Xi Zhang D De‐Zhong Xu (Key Laboratory of Radiopharmaceuticals Ministry of Education College of Chemistry Beijing Normal University Beijing 100875 P.R. China) W Wen‐Jing Zhao (Key Laboratory of Radiopharmaceuticals Ministry of Education College of Chemistry Beijing Normal University Beijing 100875 P.R. China) X Xin‐Yue Han (Key Laboratory of Radiopharmaceuticals Ministry of Education College of Chemistry Beijing Normal University Beijing 100875 P.R. China) Z Zhong‐Lin Lu (Key Laboratory of Radiopharmaceuticals Ministry of Education College of Chemistry Beijing Normal University Beijing 100875 P.R. China) R Rui Liu

Abstract

Abstract Gene therapy (GT) and photodynamic therapy (PDT) present promising approaches for cancer treatment. However, GT is frequently impeded by the lysosomal capture of nucleic acids, while PDT is constrained by low oxygen levels in tumors. Herein, we reported the design of a versatile block polyester vector, BFN 2 , which comprises of a photosensitizer BODIPY ( B ), an oxygen carrying perfluorinated carbon chain ( F ) as well as a GSH‐responsive, and RNA‐condensing [12]aneN 3 ( N ) moiety. In the presence of DOPE ( D ) and DSPE‐PEG‐iRGD ( R ), BFN 2 is able to carry oxygen and condense HIF‐1α siRNA efficiently and afford hybrid nanoparticles BFN 2 DR/HIF‐1α siRNA@O₂ . These combined functionalities work together to reverse tumor hypoxia, remodel the tumor microenvironment, and allow for the efficient lysosomal escape of nucleic acids, thereby significantly boosting the efficacy of PDT and GT in solid tumors. In vitro and in vivo studies demonstrated that the BFN 2 ‐DR/HIF‐1α siRNA@O₂ nanoplatform significantly exhibited substantial inhibitory effects in 4T1 tumors with TGI up to 87%. This research marks the first‐in‐class integration of such multimodality therapeutic strategies within a single block polymeric vector, thus offering a novel perspective for developing effective oncological treatment paradigms.

Article Details

Volume / Issue Vol. 64, Issue 33
Published August 11, 2025
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (6)

X

Xi Zhang

D

De‐Zhong Xu

Key Laboratory of Radiopharmaceuticals Ministry of Education College of Chemistry Beijing Normal University Beijing 100875 P.R. China

W

Wen‐Jing Zhao

Key Laboratory of Radiopharmaceuticals Ministry of Education College of Chemistry Beijing Normal University Beijing 100875 P.R. China

X

Xin‐Yue Han

Key Laboratory of Radiopharmaceuticals Ministry of Education College of Chemistry Beijing Normal University Beijing 100875 P.R. China

Z

Zhong‐Lin Lu

Key Laboratory of Radiopharmaceuticals Ministry of Education College of Chemistry Beijing Normal University Beijing 100875 P.R. China

R

Rui Liu